Zkusit zdarma
Avis Budget Group, Inc.

Avis Budget Group, Inc.

CAR
Cena:
$ 166.52
-0.53 (-0.32%)
Valuace
100
Růst
53
Zdraví
50
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

8:30 21-05-2026

SAN DIEGO, May 21, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage...

Qihan Biotech Announces FDA Clearance of IND for QT-019C, a universal dual-target CAR-T candidate, marking a significant milestone in the development of a potentially low-lymphodepletion, off-the-shelf CAR-T therapy for autoimmune diseases

Qihan Biotech Announces FDA Clearance of IND for QT-019C, a universal dual-target CAR-T candidate, marking a significant milestone in the development of a potentially low-lymphodepletion, off-the-shelf CAR-T therapy for autoimmune diseases

9:00 20-05-2026

HANGZHOU, China--(BUSINESS WIRE)--Qihan Biotech, a biotechnology company dedicated to applying high-...

Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases

Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at EULAR 2026 Congress, Including Late-Breaking Oral Presentation Highlighting Clinical Efficacy Comparable to Autologous CAR T-Cell Therapy in Rheumatologic Diseases

16:05 19-05-2026

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a ...

Avis Budget's Pricing Recovery Signals Improving Industry Discipline

Avis Budget's Pricing Recovery Signals Improving Industry Discipline

10:25 19-05-2026

CAR's pricing rebound and tighter fleet management are boosting utilization and improving depreciati...

CAR's Recovery Remains Weak After Extreme Volatility: Hold or Fold?

CAR's Recovery Remains Weak After Extreme Volatility: Hold or Fold?

13:20 18-05-2026

CAR's pricing recovery and Waymo partnership offer long-term potential, but April's 70% stock collap...

Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune

Cabaletta Bio Q1 Earnings: More Positive Data Suggests CAR-T Can Work In Autoimmune

10:46 14-05-2026

Cabaletta Bio, Inc. is reaffirmed as a Buy despite recent share price volatility, driven by tangible...

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs

16:05 12-05-2026

SEATTLE, May 12, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused...

OPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

OPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

8:00 12-05-2026

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic ...

Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy

Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy

8:55 11-05-2026

Multiple patients have survived substantially beyond expected median survival, including onepatient ...

CAR Q1 Earnings Miss on Higher Fleet Charges, Revenues Beat

CAR Q1 Earnings Miss on Higher Fleet Charges, Revenues Beat

11:26 06-05-2026

Avis Budget's Q1 loss misses estimates as fleet charges stay high, but revenues beat and utilization...

Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

Fate Therapeutics Announces Three Presentations at the 2026 ASGCT Annual Meeting Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

9:00 04-05-2026

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage...

Bristol-Myers Squibb: The CAR-T Giant The Market Is Undervaluing

Bristol-Myers Squibb: The CAR-T Giant The Market Is Undervaluing

3:20 02-05-2026

Bristol Myers Squibb faces a major patent cliff but is well-equipped with a robust pipeline and sign...

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

9:00 30-04-2026

SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-sta...

A Wild Short Squeeze on Avis's Stock Takes Another Surprising Turn

A Wild Short Squeeze on Avis's Stock Takes Another Surprising Turn

17:49 29-04-2026

The rental car company says a hedge-fund firm behind the big swings owes it money because of a niche...

Avis Budget Group, Inc. (CAR) Q1 2026 Earnings Call Transcript

Avis Budget Group, Inc. (CAR) Q1 2026 Earnings Call Transcript

11:41 29-04-2026

Avis Budget Group, Inc. (CAR) Q1 2026 Earnings Call Transcript...

Avis Budget (CAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Avis Budget (CAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

11:31 29-04-2026

Although the revenue and EPS for Avis Budget (CAR) give a sense of how its business performed in the...

Avis Shares Plunges After Mixed Q1 Results

Avis Shares Plunges After Mixed Q1 Results

10:03 29-04-2026

Avis Budget Group, Inc. (NASDAQ:CAR) shares are trading lower Wednesday after the company reported m...

Avis Plummets 12%, Hertz Drops 5% – What's Going On With Car Rental Stocks?

Avis Plummets 12%, Hertz Drops 5% – What's Going On With Car Rental Stocks?

9:32 29-04-2026

Shares of Avis Budget Group (NASDAQ:CAR | CAR Price Prediction) are down roughly 12% in early Wednes...

Avis Budget Group (CAR) Reports Q1 Loss, Tops Revenue Estimates

Avis Budget Group (CAR) Reports Q1 Loss, Tops Revenue Estimates

9:25 29-04-2026

Avis Budget Group (CAR) came out with a quarterly loss of $8.01 per share versus the Zacks Consensus...

Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting

Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting

8:00 29-04-2026

BRISBANE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“T...

close

TEMPEST LAYS OUT STRATEGIC PLAN TO ADVANCE RECENTLY ACQUIRED DUAL-TARGETING CAR-T ASSETS

11-02-2026
TEMPEST OUTLINES A CAPITAL-EFFICIENT POST-TRANSACTION STRATEGY TO ADVANCE A DIVERSIFIED PORTFOLIO OF...
Více zde

ANIXA BIOSCIENCES REPORTS ENCOURAGING PATIENT SURVIVAL OBSERVATIONS IN OVARIAN CANCER CAR-T TRIAL; ACHIEVES REGULATORY APPROVAL ENABLING MAJOR DOSE ESCALATION

09-02-2026
MULTIPLE PATIENTS SUBSTANTIALLY EXCEED EXPECTED SURVIVAL AT LOW DOSE LEVELS; ABSENCE OF DOSE-LIMITIN...
Více zde

TEMPEST ANNOUNCES CLOSING OF STRATEGIC ACQUISITION OF DUAL-TARGETING CAR-T ASSETS

04-02-2026
BRISBANE, CALIF., FEB. 04, 2026 (GLOBE NEWSWIRE) -- TEMPEST THERAPEUTICS, INC. (NASDAQ: TPST) (“TE...
Více zde

FIVE KIA MODELS EARN 2026 CAR AND DRIVER EDITORS' CHOICE AWARDS

03-02-2026
IRVINE, CALIF., FEB. 3, 2026 /PRNEWSWIRE/ -- FIVE KIA MODELS WERE NAMED WINNERS OF THE 2026 CAR AND ...
Více zde

ANIXA BIOSCIENCES SECURES UNITED STATES ADOPTED NAMES COUNCIL APPROVAL OF NON-PROPRIETARY NAME FOR ITS CAR-T THERAPY, A KEY STEP TOWARD FUTURE COMMERCIALIZATION

02-02-2026
SAN JOSE, CALIF., FEB. 2, 2026 /PRNEWSWIRE/ -- ANIXA BIOSCIENCES, INC. ("ANIXA" OR THE "COMPANY") (...
Více zde

AMERICA'S CAR-MART INVESTIGATION REMINDER: BRAGAR EAGEL & SQUIRE, P.C. REMINDS CAR-MART INVESTORS TO CONTACT THE FIRM REGARDING ONGOING INVESTIGATION

22-01-2026
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

BROAD ARROW TO LIGHT UP COLLECTOR CAR MARKET WITH EXCITING PREVIEWS AT ICONIC PARIS LOCATIONS DURING RÉTROMOBILE WEEK

20-01-2026
BROAD ARROW TO HOST PREVIEW OF SELECT CARS SET FOR UPCOMING CALENDAR AT ROLAND-GARROS STADIUM FROM 2...
Více zde

AVIS BUDGET GROUP TO ANNOUNCE FOURTH QUARTER 2025 RESULTS ON FEBRUARY 18TH

15-01-2026
PARSIPPANY, N.J., JAN. 15, 2026 (GLOBE NEWSWIRE) -- AVIS BUDGET GROUP, INC. (NASDAQ: CAR) ANNOUNCED...
Více zde

ALLOGENE THERAPEUTICS POSITIONS 2026 AS A PROGRAM-DEFINING YEAR FOR SCALABLE, REAL-WORLD ALLOGENEIC CAR T

08-01-2026
SOUTH SAN FRANCISCO, CALIF., JAN. 08, 2026 (GLOBE NEWSWIRE) -- ALLOGENE THERAPEUTICS, INC. (NASDAQ: ...
Více zde

MICHAEL SCHUMACHER'S FIRST F1 GRAND PRIX-WINNING 1992 BENETTON B192-05 TO STAR IN BROAD ARROW'S GLOBAL ICONS: EUROPE ONLINE AUCTION

08-01-2026
EXTREMELY RARE OPPORTUNITY TO ACQUIRE THE F1 CAR IN WHICH MICHAEL SCHUMACHER WON HIS FIRST GRAND PRI...
Více zde

LEGEND BIOTECH HIGHLIGHTS NEW CARVYKTI® DATA IN MULTIPLE MYELOMA AND FIRST-IN-HUMAN RESULTS FROM NOVEL CAR-T PLATFORM IN NON-HODGKIN LYMPHOMA AT ASH 2025

06-12-2025
SOMERSET, N.J., DEC. 06, 2025 (GLOBE NEWSWIRE) -- LEGEND BIOTECH CORPORATION (NASDAQ: LEGN) (LEGEND ...
Více zde

BRISTOL MYERS SQUIBB'S BREYANZI APPROVED BY THE U.S. FDA AS THE FIRST AND ONLY CAR T CELL THERAPY FOR ADULTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL)

04-12-2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BREYANZI--BMS'S BREYANZI APPROVED BY THE U.S. FDA AS THE ...
Více zde

BRISTOL MYERS SQUIBB RECEIVES APPROVAL FROM THE EUROPEAN COMMISSION TO EXPAND USE OF CAR T CELL THERAPY BREYANZI FOR RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

24-11-2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BREYANZI--BMS RECEIVES APPROVAL FROM THE EUROPEAN COMMISS...
Více zde

BROAD ARROW ANNOUNCES, “GLOBAL ICONS,” AN ONLINE COLLECTOR CAR AND MEMORABILIA SALE SCHEDULED FOR JANUARY 2026

20-11-2025
NOVEL THREE-PART ONLINE AUCTION TO INCLUDE EUROPE AND UK-BASED COLLECTOR CARS ALONGSIDE MOTORSPORT M...
Více zde

TEMPEST ANNOUNCES STRATEGIC ACQUISITION OF NEW DUAL-CAR T PROGRAMS FROM FACTOR WITH SIMULTANEOUS RUNWAY EXTENSION PROJECTED TO MID 2027

19-11-2025
ALL-STOCK ACQUISITION INCLUDES CLINICAL-STAGE CD19/BCMA DUAL-CAR T PROGRAM ACQUISITION WILL EXPAND E...
Více zde

ANIXA BIOSCIENCES ANNOUNCES WORLD HEALTH ORGANIZATION (WHO) APPROVAL OF INTERNATIONAL NON-PROPRIETARY NAME FOR ITS CAR-T THERAPY, MARKING A KEY MILESTONE TOWARD GLOBAL RECOGNITION AND FUTURE COMMERCIALIZATION

17-11-2025
SAN JOSE, CALIF. , NOV. 17, 2025 /PRNEWSWIRE/ -- ANIXA BIOSCIENCES, INC. ("ANIXA" OR THE "COMPANY")...
Více zde

CARIBOU BIOSCIENCES ANNOUNCES POSITIVE DATA FROM ANTLER PHASE 1 TRIAL DEMONSTRATING EFFICACY AND DURABILITY OF VISPA-CEL (CB-010), AN ALLOGENEIC CAR-T CELL THERAPY, ON PAR WITH AUTOLOGOUS CAR-T CELL THERAPIES

03-11-2025
DATA DEMONSTRATE EFFICACY AND DURABILITY OF VISPA-CEL, AN ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY, A...
Více zde

CARIBOU BIOSCIENCES TO HOST WEBCAST TO REPORT NEW DATA UPDATES FROM TWO ALLOGENEIC CAR-T CELL THERAPY PROGRAMS IN LYMPHOMA AND MULTIPLE MYELOMA

02-11-2025
BERKELEY, CALIF., NOV. 02, 2025 (GLOBE NEWSWIRE) -- CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU), A LEAD...
Více zde

AMERICA'S CAR-MART INVESTIGATION REMINDER: BRAGAR EAGEL & SQUIRE, P.C. REMINDS CAR-MART INVESTORS TO CONTACT THE FIRM REGARDING ONGOING INVESTIGATION

01-11-2025
CAR-MART DELAYED ITS ANNUAL REPORT, RESTATED RESULTS OVER LOAN MODIFICATION ISSUES, AND LATER REPORT...
Více zde

AVIS BUDGET GROUP REPORTS THIRD QUARTER RESULTS

27-10-2025
PARSIPPANY, N.J., OCT. 27, 2025 (GLOBE NEWSWIRE) -- AVIS BUDGET GROUP, INC. (NASDAQ: CAR) ANNOUNCED ...
Více zde

CAR-MART INVESTIGATION REMINDER: BRAGAR EAGEL & SQUIRE, P.C. CONTINUES INVESTIGATION INTO AMERICA'S CAR-MART, INC. AND URGES INVESTORS TO CONTACT THE FIRM

09-10-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

AVIS BUDGET GROUP TO ANNOUNCE THIRD QUARTER 2025 RESULTS ON OCTOBER 27TH

03-10-2025
PARSIPPANY, N.J., OCT. 03, 2025 (GLOBE NEWSWIRE) -- AVIS BUDGET GROUP, INC. (NASDAQ: CAR) ANNOUNCED ...
Více zde

CAR-MART ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING AMERICA'S CAR-MART, INC. ON BEHALF OF CAR-MART STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

01-10-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

MINK THERAPEUTICS DR. JENNIFER BUELL TO DELIVER FEATURED PLENARY AT 10TH ANNUAL CAR-TCR SUMMIT IN BOSTON, MA

25-09-2025
NEW YORK, SEPT. 25, 2025 (GLOBE NEWSWIRE) -- MINK THERAPEUTICS, INC. (NASDAQ: INKT), A CLINICAL-STAG...
Více zde

ANIXA BIOSCIENCES AND MOFFITT CANCER CENTER COMPLETE DOSING OF FOURTH COHORT IN OVARIAN CANCER CAR-T CLINICAL TRIAL; MULTIPLE PATIENTS SURPASSING MEDIAN EXPECTED SURVIVAL

08-09-2025
CONTINUE TO OBSERVE A POSITIVE SAFETY PROFILE—NO DOSE LIMITING TOXICITIES, CYTOKINE RELEASE SYNDRO...
Více zde

BROAD ARROW PRESENTS ASTON MARTIN VALKYRIE OWNED BY DANIEL RICCIARDO AT ZOUTE CONCOURS AUCTION

03-09-2025
ASTON MARTIN VALKYRIE HYPERCAR COMMISSIONED BY DANIEL RICCIARDO TO HIS PERSONAL SPECIFICATION | AUCT...
Více zde

KYVERNA THERAPEUTICS HIGHLIGHTS NEUROIMMUNOLOGY CAR T FRANCHISE AND REGISTRATIONAL PHASE 3 TRIAL DESIGN IN MYASTHENIA GRAVIS AT VIRTUAL KOL EVENT

28-08-2025
KYV-101 HAS THE POTENTIAL TO DELIVER DURABLE, DRUG-FREE, DISEASE-FREE REMISSION IN MYASTHENIA GRAVIS...
Více zde

CHARLES RIVER JOINS EASYGEN CONSORTIUM, SUPPORTS DEVELOPMENT OF BEDSIDE CAR-T MANUFACTURING

26-08-2025
WILMINGTON, MASS.--(BUSINESS WIRE)---- $CRL #LIFEATCRL--CHARLES RIVER JOINS EASYGEN TO PROVIDE 3D SC...
Více zde

ANIXA BIOSCIENCES ANNOUNCES TREATMENT OF SECOND PATIENT IN FOURTH COHORT OF OVARIAN CANCER CAR-T CLINICAL TRIAL

18-08-2025
FOURTH COHORT RECEIVING 30X INITIAL DOSE WITH NO DOSE-LIMITING TOXICITIES OBSERVED TO DATE SAN JOSE...
Více zde

ANIXA BIOSCIENCES ANNOUNCES ISSUANCE OF ADDITIONAL U.S. PATENT FOR CAR-T TECHNOLOGY

12-08-2025
NEWLY ISSUED PATENT EXTENDS PROTECTION OF PROPRIETARY SOLID TUMOR CAR-T PLATFORM TO 2045 SAN JOSE, C...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-05 00:00:008-KStáhnout
2025-10-28 00:00:0010-QStáhnout
2025-10-27 00:00:008-KStáhnout
2025-09-19 01:00:008-KStáhnout
2025-09-19 00:00:008-KStáhnout
2025-09-08 01:00:008-KStáhnout
2025-09-08 00:00:008-KStáhnout
2025-07-31 01:00:008-KStáhnout
2025-07-31 00:00:008-KStáhnout
2025-07-30 01:00:0010-QStáhnout
2025-07-30 00:00:0010-QStáhnout
2025-07-29 01:00:008-KStáhnout
2025-07-29 00:00:008-KStáhnout
2025-07-21 01:00:008-KStáhnout
2025-07-21 00:00:008-KStáhnout
2025-06-09 01:00:008-KStáhnout
2025-06-09 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-19 01:00:008-KStáhnout
2025-05-19 00:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-05-07 01:00:008-KStáhnout
2025-05-07 00:00:008-KStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 00:00:008-KStáhnout
2025-02-14 00:00:0010-KStáhnout
2025-02-13 23:00:0010-KStáhnout
2025-02-11 00:00:008-KStáhnout
2025-02-10 23:00:008-KStáhnout
2024-11-01 00:00:0010-QStáhnout
2024-10-31 23:00:0010-QStáhnout
2024-10-31 00:00:008-KStáhnout
2024-10-30 23:00:008-KStáhnout
2024-09-13 01:00:008-KStáhnout
2024-09-13 00:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-08-05 01:00:008-KStáhnout
2024-08-05 00:00:008-KStáhnout
2024-05-24 01:00:008-KStáhnout
2024-05-24 00:00:008-KStáhnout
2024-05-21 01:00:008-KStáhnout
2024-05-21 00:00:008-KStáhnout
2024-05-02 01:00:0010-QStáhnout
2024-05-02 00:00:0010-QStáhnout
2024-05-01 01:00:008-KStáhnout
2024-05-01 00:00:008-KStáhnout
2024-03-18 00:00:008-KStáhnout
2024-03-17 23:00:008-KStáhnout
2024-03-08 00:00:008-KStáhnout
2024-03-07 23:00:008-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-16 00:00:0010-KStáhnout
2024-02-15 23:00:0010-KStáhnout
2024-02-12 00:00:008-KStáhnout
2024-02-11 23:00:008-KStáhnout
2024-01-18 00:00:008-KStáhnout
2024-01-17 23:00:008-KStáhnout
2024-01-03 00:00:008-KStáhnout
2024-01-02 23:00:008-KStáhnout
2023-12-14 00:00:008-KStáhnout
2023-12-13 23:00:008-KStáhnout
2023-12-06 00:00:008-KStáhnout
2023-12-05 23:00:008-KStáhnout
2023-11-22 00:00:008-KStáhnout
2023-11-21 23:00:008-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-11-01 00:00:008-KStáhnout
2023-10-31 23:00:008-KStáhnout
2023-09-21 01:00:008-KStáhnout
2023-09-21 00:00:008-KStáhnout
2023-08-01 01:00:0010-QStáhnout
2023-08-01 00:00:0010-QStáhnout
2023-07-31 01:00:008-KStáhnout
2023-07-31 00:00:008-KStáhnout
2023-07-14 01:00:008-KStáhnout
2023-07-14 00:00:008-KStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-05-26 01:00:008-KStáhnout
2023-05-26 00:00:008-KStáhnout
2023-05-02 01:00:0010-QStáhnout
2023-05-02 00:00:0010-QStáhnout
2023-05-01 01:00:008-KStáhnout
2023-05-01 00:00:008-KStáhnout
2023-04-28 01:00:008-KStáhnout
2023-04-28 00:00:008-KStáhnout
2023-04-12 01:00:008-KStáhnout
2023-04-12 00:00:008-KStáhnout
2023-04-04 01:00:008-KStáhnout
2023-04-04 00:00:008-KStáhnout
2023-02-16 00:00:0010-KStáhnout
2023-02-15 23:00:0010-KStáhnout
2023-02-13 00:00:008-KStáhnout
2023-02-12 23:00:008-KStáhnout
2023-01-20 00:00:008-KStáhnout
2023-01-19 23:00:008-KStáhnout
2022-12-27 00:00:008-KStáhnout
2022-12-26 23:00:008-KStáhnout
2022-12-02 00:00:008-KStáhnout
2022-12-01 23:00:008-KStáhnout
2022-11-01 00:00:0010-QStáhnout
2022-10-31 23:00:0010-QStáhnout
2022-10-31 00:00:008-KStáhnout
2022-10-30 23:00:008-KStáhnout
2022-08-02 01:00:0010-QStáhnout
2022-08-02 00:00:0010-QStáhnout
2022-08-01 01:00:008-KStáhnout
2022-08-01 00:00:008-KStáhnout
2022-07-22 01:00:008-KStáhnout
2022-07-22 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-03 01:00:0010-QStáhnout
2022-05-03 00:00:0010-QStáhnout
2022-05-02 01:00:008-KStáhnout
2022-05-02 00:00:008-KStáhnout
2022-04-22 01:00:008-KStáhnout
2022-04-22 00:00:008-KStáhnout
2022-04-19 01:00:008-KStáhnout
2022-04-19 00:00:008-KStáhnout
2022-03-28 01:00:008-KStáhnout
2022-03-28 00:00:008-KStáhnout
2022-03-16 00:00:008-KStáhnout
2022-03-15 23:00:008-KStáhnout
2022-02-17 00:00:0010-KStáhnout
2022-02-16 23:00:0010-KStáhnout
2022-02-14 00:00:008-KStáhnout
2022-02-13 23:00:008-KStáhnout
2021-12-10 00:00:008-KStáhnout
2021-12-09 23:00:008-KStáhnout
2021-12-09 00:00:008-KStáhnout
2021-12-08 23:00:008-KStáhnout
2021-11-19 00:00:008-KStáhnout
2021-11-18 23:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-09-28 01:00:008-KStáhnout
2021-09-28 00:00:008-KStáhnout
2021-09-15 01:00:008-KStáhnout
2021-09-15 00:00:008-KStáhnout
2021-08-04 01:00:0010-QStáhnout
2021-08-04 00:00:0010-QStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 00:00:008-KStáhnout
2021-07-13 01:00:008-KStáhnout
2021-07-13 00:00:008-KStáhnout
2021-06-23 01:00:008-KStáhnout
2021-06-23 00:00:008-KStáhnout
2021-06-04 01:00:008-KStáhnout
2021-06-04 00:00:008-KStáhnout
2021-05-27 01:00:008-KStáhnout
2021-05-27 00:00:008-KStáhnout
2021-05-21 01:00:008-KStáhnout
2021-05-21 00:00:008-KStáhnout
2021-05-04 01:00:0010-QStáhnout
2021-05-04 00:00:0010-QStáhnout
2021-05-03 01:00:008-KStáhnout
2021-05-03 00:00:008-KStáhnout
2021-03-23 00:00:008-KStáhnout
2021-03-22 23:00:008-KStáhnout
2021-03-01 00:00:008-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-17 00:00:008-KStáhnout
2021-02-17 00:00:0010-KStáhnout
2021-02-16 23:00:008-KStáhnout
2021-02-16 23:00:0010-KStáhnout
2021-02-16 00:00:008-KStáhnout
2021-02-15 23:00:008-KStáhnout
2020-12-14 00:00:008-KStáhnout
2020-12-13 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-08 23:00:008-KStáhnout
2020-10-30 00:00:0010-QStáhnout
2020-10-29 23:00:0010-QStáhnout
2020-10-29 00:00:008-KStáhnout
2020-10-28 23:00:008-KStáhnout
2020-08-14 01:00:008-KStáhnout
2020-08-14 00:00:008-KStáhnout
2020-08-13 01:00:008-KStáhnout
2020-08-13 00:00:008-KStáhnout
2020-08-07 01:00:008-KStáhnout
2020-08-07 00:00:008-KStáhnout
2020-07-29 01:00:0010-QStáhnout
2020-07-29 00:00:0010-QStáhnout
2020-07-28 01:00:008-KStáhnout
2020-07-28 00:00:008-KStáhnout
2020-06-15 01:00:008-KStáhnout
2020-06-15 00:00:008-KStáhnout
2020-05-21 01:00:008-KStáhnout
2020-05-21 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-08 01:00:008-KStáhnout
2020-05-08 00:00:008-KStáhnout
2020-05-05 01:00:008-KStáhnout
2020-05-05 00:00:008-KStáhnout
2020-05-01 01:00:0010-QStáhnout
2020-05-01 00:00:0010-QStáhnout
2020-04-29 01:00:008-KStáhnout
2020-04-29 00:00:008-KStáhnout
2020-04-27 01:00:008-KStáhnout
2020-04-27 00:00:008-KStáhnout
2020-04-23 01:00:008-KStáhnout
2020-04-23 00:00:008-KStáhnout
2020-03-23 00:00:008-KStáhnout
2020-03-22 23:00:008-KStáhnout
2020-03-20 00:00:008-KStáhnout
2020-03-19 23:00:008-KStáhnout
2020-02-24 00:00:008-KStáhnout
2020-02-23 23:00:008-KStáhnout
2020-02-20 00:00:0010-KStáhnout
2020-02-19 23:00:0010-KStáhnout
2020-02-19 00:00:008-KStáhnout
2020-02-18 23:00:008-KStáhnout
2020-02-10 00:00:008-KStáhnout
2020-02-09 23:00:008-KStáhnout
2020-02-07 00:00:008-KStáhnout
2020-02-06 23:00:008-KStáhnout
2020-01-29 00:00:008-KStáhnout
2020-01-28 23:00:008-KStáhnout
2020-01-28 00:00:008-KStáhnout
2020-01-27 23:00:008-KStáhnout
2019-12-30 00:00:008-KStáhnout
2019-12-29 23:00:008-KStáhnout
2019-11-01 00:00:0010-QStáhnout
2019-10-31 23:00:0010-QStáhnout
2019-10-31 00:00:008-KStáhnout
2019-10-30 23:00:008-KStáhnout
2019-08-29 01:00:008-KStáhnout
2019-08-29 00:00:008-KStáhnout
2019-08-06 01:00:008-KStáhnout
2019-08-06 01:00:0010-QStáhnout
2019-08-06 00:00:008-KStáhnout
2019-08-06 00:00:0010-QStáhnout
2019-06-18 01:00:008-KStáhnout
2019-06-18 00:00:008-KStáhnout
2019-05-31 01:00:008-KStáhnout
2019-05-31 00:00:008-KStáhnout
2019-05-23 01:00:008-KStáhnout
2019-05-23 00:00:008-KStáhnout
2019-05-02 01:00:0010-QStáhnout
2019-05-02 00:00:0010-QStáhnout
2019-05-01 01:00:008-KStáhnout
2019-05-01 00:00:008-KStáhnout
2019-04-29 01:00:008-KStáhnout
2019-04-29 00:00:008-KStáhnout
2019-03-18 00:00:008-KStáhnout
2019-03-17 23:00:008-KStáhnout
2019-02-21 00:00:0010-KStáhnout
2019-02-20 23:00:0010-KStáhnout
2019-02-20 00:00:008-KStáhnout
2019-02-19 23:00:008-KStáhnout
2019-02-19 00:00:008-KStáhnout
2019-02-18 23:00:008-KStáhnout
2018-11-06 00:00:0010-QStáhnout
2018-11-05 23:00:0010-QStáhnout
2018-11-05 00:00:008-KStáhnout
2018-11-04 23:00:008-KStáhnout
2018-10-30 00:00:008-KStáhnout
2018-10-29 23:00:008-KStáhnout
2018-08-08 01:00:0010-QStáhnout
2018-08-08 00:00:0010-QStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 00:00:008-KStáhnout
2018-06-06 01:00:008-KStáhnout
2018-06-06 00:00:008-KStáhnout
2018-05-24 01:00:008-KStáhnout
2018-05-24 00:00:008-KStáhnout
2018-05-04 01:00:008-KStáhnout
2018-05-04 00:00:008-KStáhnout
2018-05-03 01:00:0010-QStáhnout
2018-05-03 00:00:0010-QStáhnout
2018-05-02 01:00:008-KStáhnout
2018-05-02 00:00:008-KStáhnout
2018-04-24 01:00:008-KStáhnout
2018-04-24 00:00:008-KStáhnout
2018-04-16 01:00:008-KStáhnout
2018-04-16 00:00:008-KStáhnout
2018-02-22 00:00:0010-KStáhnout
2018-02-21 23:00:0010-KStáhnout
2018-02-21 00:00:008-KStáhnout
2018-02-20 23:00:008-KStáhnout
2018-02-16 00:00:008-KStáhnout
2018-02-15 23:00:008-KStáhnout
2018-01-16 00:00:008-KStáhnout
2018-01-15 23:00:008-KStáhnout
2017-12-19 00:00:008-KStáhnout
2017-12-18 23:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-11-06 00:00:008-KStáhnout
2017-11-05 23:00:008-KStáhnout
2017-11-03 00:00:008-KStáhnout
2017-11-02 23:00:008-KStáhnout
2017-08-31 01:00:008-KStáhnout
2017-08-31 00:00:008-KStáhnout
2017-08-24 01:00:008-KStáhnout
2017-08-24 00:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-08-07 01:00:008-KStáhnout
2017-08-07 00:00:008-KStáhnout
2017-06-08 01:00:008-KStáhnout
2017-06-08 00:00:008-KStáhnout
2017-05-22 01:00:008-KStáhnout
2017-05-22 00:00:008-KStáhnout
2017-05-19 01:00:008-KStáhnout
2017-05-19 00:00:008-KStáhnout
2017-05-18 01:00:008-KStáhnout
2017-05-18 00:00:008-KStáhnout
2017-05-04 01:00:0010-QStáhnout
2017-05-04 00:00:0010-QStáhnout
2017-05-03 01:00:008-KStáhnout
2017-05-03 00:00:008-KStáhnout
2017-03-21 00:00:008-KStáhnout
2017-03-20 23:00:008-KStáhnout
2017-03-09 00:00:008-KStáhnout
2017-03-08 23:00:008-KStáhnout
2017-02-21 00:00:0010-KStáhnout
2017-02-20 23:00:0010-KStáhnout
2017-02-15 00:00:008-KStáhnout
2017-02-14 23:00:008-KStáhnout
2017-01-25 00:00:008-KStáhnout
2017-01-24 23:00:008-KStáhnout
2017-01-23 00:00:008-KStáhnout
2017-01-22 23:00:008-KStáhnout
2016-12-15 00:00:008-KStáhnout
2016-12-14 23:00:008-KStáhnout
2016-11-22 00:00:008-KStáhnout
2016-11-21 23:00:008-KStáhnout
2016-11-03 00:00:008-KStáhnout
2016-11-03 00:00:0010-QStáhnout
2016-11-02 23:00:008-KStáhnout
2016-11-02 23:00:0010-QStáhnout
2016-11-02 00:00:008-KStáhnout
2016-11-01 23:00:008-KStáhnout
2016-10-12 01:00:008-KStáhnout
2016-10-12 00:00:008-KStáhnout
2016-08-31 01:00:008-KStáhnout
2016-08-31 00:00:008-KStáhnout
2016-08-03 01:00:0010-QStáhnout
2016-08-03 00:00:0010-QStáhnout
2016-08-02 01:00:008-KStáhnout
2016-08-02 00:00:008-KStáhnout
2016-06-07 01:00:008-KStáhnout
2016-06-07 00:00:008-KStáhnout
2016-05-26 01:00:008-KStáhnout
2016-05-26 00:00:008-KStáhnout
2016-05-04 01:00:0010-QStáhnout
2016-05-04 00:00:0010-QStáhnout
2016-05-03 01:00:008-KStáhnout
2016-05-03 00:00:008-KStáhnout
2016-04-21 01:00:008-KStáhnout
2016-04-21 00:00:008-KStáhnout
2016-04-05 01:00:008-KStáhnout
2016-04-05 00:00:008-KStáhnout
2016-03-29 01:00:008-KStáhnout
2016-03-29 00:00:008-KStáhnout
2016-03-22 00:00:008-KStáhnout
2016-03-21 23:00:008-KStáhnout
2016-02-24 00:00:0010-KStáhnout
2016-02-23 23:00:0010-KStáhnout
2016-02-23 00:00:008-KStáhnout
2016-02-22 23:00:008-KStáhnout
2016-01-28 00:00:008-KStáhnout
2016-01-27 23:00:008-KStáhnout
2016-01-25 00:00:008-KStáhnout
2016-01-24 23:00:008-KStáhnout
2015-11-24 00:00:008-KStáhnout
2015-11-23 23:00:008-KStáhnout
2015-11-03 00:00:0010-QStáhnout
2015-11-02 23:00:0010-QStáhnout
2015-11-02 00:00:008-KStáhnout
2015-11-01 23:00:008-KStáhnout
2015-09-18 01:00:008-KStáhnout
2015-09-18 00:00:008-KStáhnout
2015-08-20 01:00:008-KStáhnout
2015-08-20 00:00:008-KStáhnout
2015-08-04 01:00:0010-QStáhnout
2015-08-04 00:00:0010-QStáhnout
2015-08-03 01:00:008-KStáhnout
2015-08-03 00:00:008-KStáhnout
2015-05-29 01:00:008-KStáhnout
2015-05-29 00:00:008-KStáhnout
2015-05-20 01:00:008-KStáhnout
2015-05-20 00:00:008-KStáhnout
2015-05-06 01:00:008-KStáhnout
2015-05-06 00:00:008-KStáhnout
2015-05-05 01:00:0010-QStáhnout
2015-05-05 00:00:0010-QStáhnout
2015-05-04 01:00:008-KStáhnout
2015-05-04 00:00:008-KStáhnout
2015-04-22 01:00:008-KStáhnout
2015-04-22 00:00:008-KStáhnout
2015-04-06 01:00:008-KStáhnout
2015-04-06 00:00:008-KStáhnout
2015-03-17 00:00:008-KStáhnout
2015-03-16 23:00:008-KStáhnout
2015-03-10 00:00:008-KStáhnout
2015-03-09 23:00:008-KStáhnout
2015-02-23 00:00:0010-KStáhnout
2015-02-22 23:00:0010-KStáhnout
2015-02-18 00:00:008-KStáhnout
2015-02-17 23:00:008-KStáhnout
2015-01-30 00:00:008-KStáhnout
2015-01-29 23:00:008-KStáhnout
2014-12-19 00:00:008-KStáhnout
2014-12-18 23:00:008-KStáhnout
2014-11-26 00:00:008-KStáhnout
2014-11-25 23:00:008-KStáhnout
2014-11-18 23:00:008-KStáhnout
preloader